ArticleBritish journal of cancer2014

Biliverdin's regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer.

J Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.